From HCV to HEV: Repurposing a nucleoside analogue for hepatitis E therapy. Sandmann L. J Hepatol 2025 Jul 31:S0168-8278(25)02322-0. doi: 10.1016/j.jhep.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Sandmann L. From HCV to HEV: Repurposing a nucleoside analogue for hepatitis E therapy. J Hepatol 2025 Jul 31:S0168-8278(25)02322-0. doi: 10.1016/j.jhep.2025.
PMID: 40750477